PolyPid Competitors and Similar CompaniesClear all

Metabolon's competitors and similar companies include Adaptimmune and Meissa Vaccines.
Metabolon
Metabolon
Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
Adaptimmune
Adaptimmune
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Meissa Vaccines
Meissa Vaccines
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
Founding Date
Founding Date
2000
Founding Date
2008
Founding Date
2014
Type
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Morrisville, US HQ
Hallbergmoos, DE
München, DE
Locations
Philadelphia, US HQ
Milton, GB
Milton, GB
Stevenage, GB
Locations
South San Francisco, US HQ
Redwood City, US
Employees
Employees
1911% increase
Employees
4007% decrease
Employees
3

Funding

Latest funding round
Latest funding round
$ 15m (over 9 years ago)
Latest funding round
N/A
Latest funding round
$ 30m (over 6 years ago)
Total funding raised
Total funding raised
$ 95.4m
Total funding raised
$ 107.5m
Total funding raised
$ 33.4m
For sources of this data, please see the company profile

View Company Profiles

Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease

Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

View company
Meissa Vaccines
HQ
South San Francisco, US
Employees
3

Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.

View company